-
Commentary: Its harder for women to get ahead in business, thanks to pay inequality and other factors, says ACI Specialty Benefits Erin Krehbiel. But, they can do something about it.
March 31
ACI Specialty Benefits -
UnitedHealth Groups $12.8 billion purchase of pharmacy benefit manager Catamaran Corp. continues a trend of PBM acquisitions, and theres more to come, industry consultants say. In the long term, that may mean lower costs and more data availability for employers.
March 30 -
Commentary: Three reasons Individual contracts are incompatible with ERISA plans and how to handle it, according to The Principals Aaron Friedman.
March 30
Principal Financial Group -
Commentary: While these FMLA changes dont require any immediate action or changes to employers benefit plans, they could serve as a catalyst for federal officials and agencies to further extend their reach into benefits programs, says Sam Fleet.
March 30
AmWINS Group Benefits -
UnitedHealth Group Inc. agreed to buy Catamaran Corp. for about $12.8 billion, bulking up its drug-benefits business to get better negotiating power in talks with pharmaceutical companies over prices.
March 30 -
For many taxpayers, their first introduction to the ACA may be the Form 1095-A that they receive in the mail, and bring with them or forget to bring with them to their tax preparer. Many have questions about the form, and state exchange call centers have been inundated with inquiries. Here are top five questions being asked about Form 1095-A.
March 30 -
Theres room to grow in the investment-only variable annuity space, and educated advisers are the key.
March 30 -
Continued lawsuits over excessive 401(k) fees are on track to force providers to change the way they deliver products and end a practice that appears to be a showcase of impropriety.
March 27 -
Commentary: It depends, says Borislow Insurances Mark Gaunya, who points to the Massachusetts system. The national model must evolve first.
March 27
Borislow Insurance -
Aetna has agreed to reduce out-of-pocket payments for most HIV and AIDS medicines after pressure from an advocacy group, revising coverage that had some patients paying $1,000 a month for the drugs.
March 27


